DigitCells retweeted
Congratulations to the winners of the 2026 @CAPA_comm x GoPath Best Abstract Award! ๐๐
We are so proud to celebrate the outstanding research & dedication of this year's recipients, whose work spans cutting-edge topics in spatial transcriptomics, genomics, & digital pathology.
DigitCells retweeted
What if a routine stain from your lab could change 1 in 8 prostate core diagnoses? Our new study shows that adding PIN4 to all prostate needle cores often refines initial H&E findings. See how the use of PIN4 can support confident treatment planning.
๐: gopathdx.com/blog/tpost/f459โฆ
DigitCells retweeted
Join us at the 2025 @UrologyUS Annual Meeting to see how our latest genomic and genetic testing solutions are helping urologists deliver more precise, data-driven care. Our solutions include:
โ
PROSTATENOW
โ
OncoTarget 500
โ
Integrated Genomic Tools
DigitCells retweeted
Our CEO, Dr. Jim Lu, was recently featured in the @FLPathologists 'Get to Know' series.
Dr. Lu reflects on his journey from GI & liver pathology to launching GoPath Diagnostics, where he now leads efforts in advancing molecular & digital diagnostics.
flpath.org/content/get-know-โฆ
DigitCells retweeted
GoPath Diagnostics announces the launch of DiabetesNow, a comprehensive genetic panel developed to assist with the diagnosis, classification, and management of diabetes.
๐ Read the full press release: globenewswire.com/news-releaโฆ
#Genetics #Diabetes
DigitCells retweeted
A recent evidence-based analysis evaluated the genes recommended by NCCN guidelines for germline testing in prostate cancer. This research critically evaluates the current NCCN recommendations for genetic testing in prostate cancer patients.
Read more: onlinelibrary.wiley.com/doi/โฆ
DigitCells retweeted
Thank you for helping to raise awareness!
May is #BladderCancerAwarenessMonth.
Bladder cancerย is the sixth most common in the U.S., with an estimated 84,870ย new cases & 17,420 deaths expected in 2025.
Learn how you can get involved with @BladderCancerUS: bcan.org
DigitCells retweeted
๐๐๐ญ๐ก๐จ๐ฅ๐จ๐ ๐ข๐ฌ๐ญ๐ฌ, ๐๐ฏ๐๐ซ๐ฐ๐ก๐๐ฅ๐ฆ๐๐ ๐๐ฒ ๐๐๐ญ๐? ๐๐ ๐๐๐ง ๐๐๐ฅ๐ฉโ๐๐๐ซ๐โ๐ฌ ๐๐จ๐ฐ! ๐งช๐ก
Pathologists juggle mountains of diagnostic dataโpathology reports, molecular tests, and complex โomicsโ results. Itโs a lot! And sorting through it all manually? Exhausting! ๐ฉ
In a recent article, Scott Kilcoyne, COO and Cofounder of @DigitCells, discusses how AI can help. The secret sauce? Prompt engineering. ๐
With the right prompts, you can get large language models (LLMs) to do the heavy liftingโsummarizing reports, spotting discrepancies, prioritizing treatment options, and even integrating multi-omics data. โก
๐น Need a quick pathology report summary? Thereโs a prompt for that.
๐น Want to flag inconsistencies in test results? AIโs got your back.
๐น Looking for actionable mutations? Just ask, the right way.
While AI-powered labs are the future, you donโt have to wait. Mastering smart prompts turns overwhelming data into actionable insights. ๐ฌ
Time to work smarter, not harder!
To read Scott's full article, click our Pathology News link:
pathologynews.com/industry-nโฆ
Do you sometimes feel overwhelmed by your workload? Let us know in the comments.
#pathologynews #digitalpathology
DigitCells retweeted
๐ ๐๐จ๐ฉ ๐๐ ๐๐ซ๐๐๐ญ ๐๐ก๐ข๐ง๐ ๐ฌ ๐๐จ๐ฎโ๐ซ๐ ๐๐จ๐ข๐ง๐ (๐๐ง๐ ๐๐ก๐จ๐ฎ๐ฅ๐ ๐๐ ๐๐จ๐ข๐ง๐ ) ๐๐จ๐ซ ๐๐จ๐ฎ๐ซ ๐๐๐ญ๐ก๐จ๐ฅ๐จ๐ ๐ฒ ๐๐ง๐ ๐๐ง๐๐จ๐ฅ๐จ๐ ๐ฒ ๐๐จ๐๐ญ๐ฐ๐๐ซ๐
๐ง In his latest article on Pathology News, Scott Kilcoyne, DigitCells'Cofounder and COO, shares his insights into how the fields of pathology and oncology are rapidly evolving to create opportunities for innovative software development.
๐ฅ๏ธ Leading developers prioritize security, interoperability, AI integration, and predictive analytics to enhance patient care. They leverage diverse data sources, ensure regulatory compliance, and design intuitive, user-friendly interfaces. Blended development teams help maintain relevance in the US healthcare market, while robust data governance safeguards sensitive patient information. Developers also focus on ethical AI, minimizing bias and ensuring transparency.
๐ By anticipating future needs, fostering collaboration, and refining usability, software solutions can drive efficiency and improve clinical outcomes. Implementing these strategies will shape the next generation of healthcare tools.
To read Scott's full article, click our Pathology News link:pathologynews.com/industry-nโฆ
What are your thoughts on this? Reach out to us in the comments below and let's start a discussion. ๐
#pathology #oncology #digitalpathology
DigitCells retweeted
๐๐๐ก๐ ๐๐จ๐ฅ๐ ๐จ๐ ๐๐ ๐ข๐ง ๐๐จ๐๐๐ซ๐ง ๐๐๐ญ๐ก๐จ๐ฅ๐จ๐ ๐ฒ๐
Cofounder and COO of @DigitCells, Scott Kilcoyne, recently provided insights into the role of AI in modern pathology.
๐ก@AlphaGoโs legendary โMove 37โ showcased AIโs ability to strategize beyond human intuition, offering a powerful analogy for its role in pathology and oncology.๐ก
๐ง Like Go, disease diagnosis demands complex pattern recognition and strategic insight. AI, integrating digital pathology, multi-omics, and real-time liquid biopsies, can uncover hidden disease patterns, predict therapy responses, and optimize treatmentsโmirroring a Go masterโs board-wide strategy. ๐ง
As virtual twins and AI-driven diagnostics advance, medicine must embrace this โGo paradigmโ, shifting from reactive approaches to strategic disease management. The future of cancer diagnostics lies in AI as a strategic partner, unlocking new possibilities in precision medicine. ๐ฏ๐จโ๐ฌ
Read the full article on Pathology News: pathologynews.com/industry-nโฆ
#digitalpathology
DigitCells retweeted
Congratulations to the 2025 @CAPA_comm-GoPath Best Abstract Award winners!
After a blind review of 42 outstanding submissions, the CAPA Award Committee recognized top academic contributions spanning AI to Thoracic Pathology. Please join us in celebrating all the participants in these remarkable achievements!
Learn more about the awards: 887m.redundant-webservers.coโฆ
DigitCells retweeted
We sleighed our holiday lunch yesterdayโno Grinch could steal these smiles! ๐
โจ
DigitCells retweeted
Join us at the 2024 @UrologyUS annual meeting to discover innovations that can reshape patient care in urology. Our latest genomic and genetic testing solutions offer powerful insights for targeted treatment and proactive risk management.
Hereโs what weโre excited to share:
๐ธ PROSTATENOW: Advanced genetic testing for a precise prostate cancer risk assessment approach.
๐ธ Comprehensive Genomic Solutions: From early diagnosis to tailored treatment plans, we support the unique demands of urologic care.
๐ธ Clinical Integration Made Easy: Learn how to bring these genomic tools seamlessly into your practice, enhancing decision-making and patient outcomes.
๐ธ OncoTarget 500: Access actionable genomic analyses on hundreds of cancer-related genes, helping you fine-tune individualized treatment options.
๐ Learn more: gopathdx.com/genomic-programโฆ













